From raw FCS file to finalized report, AI-powered CellStudio streamlines your workflow. Built for cytometrists and hematologists, CellStudio keeps you in control at every step.
CellStudio Connect automatically picks up FCS/LMD files from your flow cytometer and uploads them to the hema.to cloud, fully anonymized.
Measures FCS/LMD data
Anonymizes and uploads the data
Securely stores and analyzes the data
CellStudio’s lasso tool allows detailed and versatile event selection and assignment across scatter plots. Phenotypes and cell counts update in real-time in response to event selections and annotations you apply.
Cases can be prioritized, assigned to people and a Workflow Status, as well as filtered in the Case List.
CellStudio automatically creates annotation versions and audit logs for every change to a case. A case’s version history can be browsed and visually compared with a few clicks.
Text, CSV or PDF? A report with your results is generated with one click, configured to your unique reporting requirements.
We use cases from your lab and combine them with hema.to’s large, internal case database to create an AI model fine-tuned to your panels and data.
CellStudio predicts a cell type for every cell in a case. Automated clustering can optionally be applied for supported cell types.
Define a target population and see its detailed phenotype and statistics. Watch it update in real time as you annotate with CellStudio’s lasso and threshold tools.
You can configure subsets based on a cell type and phenotype that will be automatically identified and added to your Cell Tree.
Cases are automatically flagged based on cell population and phenotype criteria. Hema.to comes with a full WHO-based catalogue of Flag Rules that can be added to your app with one click.
Kappa and lambda clonality is automatically assessed for B cells and their subpopulations. Detailed clonality statistics are available on a population level and can be referenced in reports.
CellStudio features a rich, intuitive suite of manual data analysis tools for flow cytometry that scales to millions of events per tube.
CellStudio is available in both a light and dark theme. You can customize the color of every cell population for either mode in your user settings.
Scatter plots can display data in linear, log and symlog scale. Axis parameters can be reconfigured seamlessly while analyzing a case.
CellStudio features a visual editor for the case’s compensation matrix. Once changed, predictions can be rerun with the updated parameters with one click.
Quickly align clusters across tubes with CellStudio’s Combined Tube. Combining is available for all cell populations and remembers your settings the next time you open a case with the same panel.
Define your Report Template for a panel or material once and have CellStudio create print-ready PDF reports with one click. CellStudio’s reports contain both free-form text as well as a detailed cell statistics section.
See and manage your team’s Case List in one central place.
Track which cases are important and who is working on them with case priorities and assignments. Filter the Case List to see your most important to-dos.
CellStudio can be configured to enforce review steps for annotations and reports to implement four-eyes principle quality controls.
Configure a template for your panels once and have CellStudio automatically apply marker mappings and Worksheet layouts to all cases.
Consistent across panels and specimen types
Peripheral blood and bone marrow
Expert-level leukocyte differentiation
Validated in pathological and non-pathological cases
I am very excited about implementing the decision support system developed by hema.to into the flow cytometry lab space! It will help streamline and automate analysis workflows leading to improved accuracy and turnaround times.”
Prof. Dr. Pozdnyakova
Director of hematopathology at UPenn Medicine
In the long run, there will be only three specialized hematology labs in the Netherlands — I think that hema.to will help us to be amongst them.”
Dr. Jürgen Riedl
Hematologist & Co-founder of Result Laboratorium
The unique A.I.-based approach developed by hema.to has a transformative potential in cytometry, filling a high unmet need for this method that provides key health and biological metrics in many indications. We are proud and thrilled to join hema.to's team in this endeavor.”
Dr. David Sourdive
Co-founder, Executive Vice President for Strategic Initiatives and Director of Cellectis
Bring a handful of your own cases and we'll walk through the entire workflow with you, from raw FCS file to finalized report.
